PerserisTM: A New and Long-Acting, Atypical Antipsychotic Drug-Delivery System
- PMID: 31447532
- PMCID: PMC6679950
PerserisTM: A New and Long-Acting, Atypical Antipsychotic Drug-Delivery System
Abstract
Perseris: A new, long-acting, atypical antipsychotic drug-delivery system.
Conflict of interest statement
Disclosure: Dr. Burdge and Dr. Karas report no financial or commercial interest in regard to this article. Professor Rey is a speaker for Alkermes PLC, Janssen.
References
-
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition: DSM-5. Washington, D.C: American Psychiatric Association; 2013.
-
- American Psychiatric Association. Practice guideline for the treatment of patients with schizophrenia. second edition. 2010. [Accessed June 17, 2019]. Available at: https://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/....
-
- Lacro JP, Dunn LB, Dolder CR, et al. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry. 2002;63(10):892–909. - PubMed
LinkOut - more resources
Full Text Sources